The 20 Best Low Potassium Level Doctors in Massachusetts, US

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Mark Desnoyers is a Cardiologist in Dartmouth,, Massachusetts. Dr. Desnoyers is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Angina, Glucocorticoid-Remediable Aldosteronism, Hypertension, and High Cholesterol.

Janewit Wongboonsin is an associate physician at the renal division at the Brigham and Women’s Hospital and part-time lecturer at Harvard Medical School. His research focuses on genomic implementation in kidney disease in low resource setting and Biobank-based genomic discovery. Dr. Wongboonsin is passionate in the application of genomic information to the care of patients with kidney disease and is involved in the development of better genetic interpretation in Alport syndrome, glomerular disease and complement mediated kidney disease via ClinGen. Dr. Wongboonsin is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Alport Syndrome, Low Potassium Level, Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, and Kidney Transplant.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

Dr. Marc Alan Pfeffer is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Victor J. Dzau professor of medicine at Harvard Medical School.Dr. Pfeffer received his medical degree from University of Oklahoma College of Medicine. He completed an internal medicine residency and a cardiology fellowship at Peter Bent Brigham Hospital (now BWH). Dr. Pfeffer is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.Dr. Pfeffer - along with Dr. Janice Pfeffer and Dr. Eugene Braunwald - is credited with introducing the concept that angiotensin-converting enzyme inhibitors (ACEIs) could mitigate adverse ventricular remodeling following myocardial infarction and that ACEI use would result in increased survival and other clinical benefits.His clinical interests include cardiovascular disease, congestive heart failure, coronary artery disease and valvular heart disease. The author of over 450 peer-reviewed publications, he has received research funding from the American Heart Association and National Institutes of Health. Dr. Pfeffer has been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr. Pfeffer is the recipient of the Clinical Research Prize and the James Herrick Award, both from the American Heart Association. Dr. Pfeffer is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, Acute Coronary Syndrome, and Pacemaker Implantation.

Gregory Hundemer is a primary care provider, practicing in Internal Medicine in Salem, Massachusetts. Dr. Hundemer is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Hyperaldosteronism, Hypertension, Low Potassium Level, High Potassium Level, and Kidney Transplant.

Hans Jeppesen is a primary care provider, practicing in Family Medicine in Salem, Massachusetts. Dr. Jeppesen is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Dementia, COVID-19, Low Potassium Level, Vertebroplasty, and Bone Graft.

Shobita Sundar is a primary care provider, practicing in Internal Medicine in Fall River, Massachusetts. Dr. Sundar is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Obesity in Children, and Low Potassium Level.

Kevin Berry is a Cardiologist in Methuen, Massachusetts. Dr. Berry is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Attack, Familial Neurocardiogenic Syncope, Apoplexy, Arrhythmias, and Pacemaker Implantation.

Carolyn Davidson is a Cardiologist in Fairhaven, Massachusetts. Dr. Davidson is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Low Potassium Level, Atrial Fibrillation, Inappropriate Sinus Tachycardia (IST), and Hypertension.

Stephen Galizio is a Cardiologist in North Andover, Massachusetts. Dr. Galizio is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Necrosis, Familial Neurocardiogenic Syncope, Hypertensive Heart Disease, and Arterial Embolism.

Melanie Hoenig is an Internal Medicine provider in Boston, Massachusetts. Dr. Hoenig is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Diabetic Nephropathy, Boils, Kidney Stones, Acute Tubular Necrosis, and Kidney Transplant.

Dr. Elazer Reuven Edelman is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and a professor of medicine at Harvard Medical School (HMS).He received his medical degree from HMS and PhD from MIT. He completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Edelman is board certified in internal medicine and cardiovascular disease.Dr. Edelman’s clinical interests include atherosclerotic arterial disease, how this condition is managed and the mechanisms that lead to unstable coronary syndrome.The author of 431 peer-reviewed articles, his research combines his scientific and medical training, using a range of engineering, biological and clinical sciences to examine the cellular and molecular mechanisms of tissue repair. His laboratory helped develop and optimize bare metal and drug-eluting stents, and used device, immune and cell biology to advance studies of endothelial cell and vascular biology. They have pioneered the computational modeling of vessel formation, and emphasized the homology between endothelial paracrine and angiocrine regulation to further delineate the elements of cancer and vascular diseases. Dr. Edelman is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Atherosclerosis, Aortic Valve Stenosis, Cardiogenic Shock, Angioplasty, and Transcatheter Aortic Valve Replacement (TAVR).

Scott Lutch is an Internal Medicine provider in Plymouth, Massachusetts. Dr. Lutch is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Inappropriate Sinus Tachycardia (IST), Familial Ventricular Tachycardia, Arrhythmias, Endoscopy, and Ureteroscopy.

Mary Frisella is a Cardiologist in Southbridge, Massachusetts. Dr. Frisella has been practicing medicine for over 27 years and is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Atrial Fibrillation, Familial Neurocardiogenic Syncope, Sitosterolemia, and Heart Failure with Preserved Ejection Fraction (HFpEF).

Steven Spiegel is an Internal Medicine provider in Norfolk, Massachusetts. Dr. Spiegel is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Minimal Change Disease, and Autosomal Dominant Polycystic Kidney Disease.

Dr. Mandeep R. Mehra is the medical director of the Brigham and Women’s Hospital (BWH) Heart and Vascular Center and the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine. He specializes in cardiovascular medicine and cardiac transplant at BWH and is a professor of medicine at Harvard Medical School.Dr. Mehra received his medical degree from Mahatma Gandhi Institute of Medical Sciences in Maharashtra, India. He completed a residency in internal medicine at Mount Carmel Medical Center in Columbus, as well as fellowships in cardiovascular disease and advanced heart failure and transplant cardiology at Ochsner Clinic Foundation Hospital in New Orleans. Dr. Mehra is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.Dr. Mehra’s clinical interests include advanced heart failure and cardiac transplantation. The author of over 200 peer-reviewed publications, his research has received support from the National Heart, Lung and Blood Institute. His recent studies focus on immunosuppression, proteomic and genomic biomarkers in peripheral blood for the prediction of cardiac rejection, as well as the effects of tobacco exposure on donor and recipient heart outcomes. Dr. Mehra is also editor-in-chief of The Journal of Heart and Lung Transplantation. Dr. Mehra is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure, COVID-19, Ventricular Fibrillation, Heart Transplant, and Thrombectomy.

Dr. Pinak Bipin Shah is director of the Cardiac Catheterization Laboratory at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Perelman School of Medicine at the University of Pennsylvania. He completed an internal medicine residency at BWH and served as chief medical resident. He then completed fellowships in cardiovascular disease, interventional cardiology and cardiovascular clinical biometrics at BWH. He is board certified in cardiovascular disease and interventional cardiology.Dr. Shah’s clinical interests include catheterization based techniques for the treatment of complex valvular and structural heart disease as well as complex coronary intervention. Dr. Shah’s practice focuses on trans-catheter aortic valve replacement (TAVR), mitral valve interventions, PFO/ASD closure, alcohol septal ablation for hypertrophic cardiomyopathy, and high-risk percutaneous coronary intervention (PCI) cases. Dr. Shah has received research funding from the Massachusetts Department of Public Health and National Heart, Lung and Blood Institute. He has also been listed one of America’s Top Doctors by Castle Connolly. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Stephen D. Wiviott, MD, FACC is a graduate of University of Pennsylvania and Harvard Medical School (HMS, Honors). He served as a Medicine resident and Chief Medical Resident at Brigham and Women’s Hospital (BWH). Following his medical residency training, he served as a Cardiology fellow at Johns Hopkins Hospital. He is Associate Professor of Medicine at Harvard Medical School, and a Senior Investigator with the TIMI study group. He attends in the Levine Cardiovascular Intensive Care Unit and general Cardiology service at Brigham and Women's Hospital.As an investigator, Dr. Wiviott has played important roles in the planning, implementation, leadership, and interpretation of multicenter, national, and international clinical trials in acute coronary syndromes including the TRITON-TIMI 38 trial, PRINCIPLE-TIMI 44 and of the TIMI 38 Coronary Stent Registry. He has also served in leadership of trials of secondary prevention of cardiovascular disease as global PI of DECLARE – TIMI 58, CAMELLIA – TIMI 61, and DAPA ACT HF – TIMI 68 assessing CV safety and efficacy of metabolic therapies.  He is the Chairman of the TIMI Clinical Events Committee and recognized as an expert in event definitions and adjudications.  Dr. Wiviott is an author of over 200 peer-reviewed publications in major medical and cardiovascular journals including 15 original articles in the New England Journal of Medicine. He was named in 2014 and 2017 by Thomson Reuters and Clarivate Analytics as one of “The World’s Most Influential Scientific Minds” and in 2016-2020 as a “Highly Cited Researcher,” recognitions inclusive of the top 1% of researchers in Clinical Medicine by citation.  Building on his trials experience, Dr. Wiviott serves as Vice President for Clinical Trials Research and Administration for Mass General Brigham and leads the Mass General Brigham Clinical Trials Office.  The CTO provides contracting, budgeting, and clinical trial management services for Mass General Brigham hospital investigators and industry sponsors and is tasked with supporting and growing clinical trials research at Mass General Brigham. Dr. Wiviott is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Angioplasty.